BioWorld

Tag Archives: ROI

Life Isn’t as Sweet as it May Seem in Biotech’s C-Suites

September 18, 2012 – 5:12 pm

Biotechnology is an idiosyncratic industry in which some executives can stake their careers on the pursuit of orphan drugs that, at best, will offer only limited opportunity for corporate profits and investors returns, while addressing the usually unmet needs of…

Share
By Michael Harris | Posted in Biotechnology, executive salaries | Also tagged , , | Comments (0)

The Public ROI from Drug Prices

May 16, 2011 – 10:16 pm

Biopharma is often the scapegoat for the escalating cost of healthcare, especially when it comes to the price of brand drugs. But since it’s hard to put a price on health and a long life, what gets lost in this…

Share
By Mari Serebrov | Posted in Big pharma, Biotechnology, Drug Approval, FDA, Healthcare reform, Orphan disease, Pharmaceutical | Also tagged | Comments (0)